{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:39:12Z","timestamp":1793032752184,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal De Pelotas","id":[{"id":"https:\/\/ror.org\/05msy9z54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00203-026-05093-0","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:34:51Z","timestamp":1785908091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-1598","authenticated-orcid":false,"given":"Suzana Lemke","family":"Lanius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Silveira","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Severo Sabedra","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilton Clair Pinto Seixas","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Ramos","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella Julli Farias","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Gessinger","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Veiras","family":"Collares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibele","family":"Borsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odir","family":"Dellagostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Larre Oliveira","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4204-2500","authenticated-orcid":false,"given":"Fabiana K\u00f6mmling","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"5093_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.033","volume":"112","author":"MKZ Babaki","year":"2017","unstructured":"Babaki MKZ, Soleimanpour S, Rezaee SA (2017) Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design. Microb Pathog 112:20\u201329. https:\/\/doi.org\/10.1016\/j.micpath.2017.08.033","journal-title":"Microb Pathog"},{"issue":"47","key":"5093_CR2","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","volume":"27","author":"RG Bastos","year":"2009","unstructured":"Bastos RG, Borsuk S, Seixas FK, Dellagostin OA (2009) Recombinant Mycobacterium bovis BCG. Vaccine 27(47):6495\u20136503. https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.044","journal-title":"Vaccine"},{"key":"5093_CR3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00253-012-4416-2","volume":"97","author":"KR Begnini","year":"2013","unstructured":"Begnini KR et al (2013) Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro. Appl Microbiol Biotechnol 97:1543\u20131552. https:\/\/doi.org\/10.1007\/s00253-012-4416-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"5093_CR4","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1007\/s00253-019-10057-0","volume":"103","author":"MLR Benitez","year":"2019","unstructured":"Benitez MLR et al (2019) Mycobacterium bovis BCG in metastatic melanoma therapy. Appl Microbiol Biotechnol 103:7903\u20137916. https:\/\/doi.org\/10.1007\/s00253-019-10057-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"5093_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1380069","volume":"15","author":"VM Borges","year":"2024","unstructured":"Borges VM et al (2024) Bacillus Calmette\u2013Gu\u00e9rin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling. Front Immunol 15:1380069. https:\/\/doi.org\/10.3389\/fimmu.2024.1380069","journal-title":"Front Immunol"},{"issue":"3","key":"5093_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"5093_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S1472-9792(12)70005-7","volume":"92","author":"MJ Brennan","year":"2012","unstructured":"Brennan MJ, Thole J (2012) Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis (Edinb) 92:6\u201313. https:\/\/doi.org\/10.1016\/S1472-9792(12)70005-7","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"5093_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00001622-200003000-00012","volume":"12","author":"LH Brinckerhoff","year":"2000","unstructured":"Brinckerhoff LH, Thompson LW, Slingluff CL Jr (2000) Melanoma vaccines. Curr Opin Oncol 12(2):163\u2013173. https:\/\/doi.org\/10.1097\/00001622-200003000-00012","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"5093_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.7150\/ijbs.118329","volume":"22","author":"MF De Almeida","year":"2026","unstructured":"De Almeida MF et al (2026) rBCG-LTAK63 outperforms BCG in bladder cancer immunotherapy: dendritic and T cell coordination drives superior tumor control in a mouse model. Int J Biol Sci 22(2):713\u2013730. https:\/\/doi.org\/10.7150\/ijbs.118329","journal-title":"Int J Biol Sci"},{"issue":"5","key":"5093_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1365-2958.1993.tb00970.x","volume":"10","author":"OA Dellagostin","year":"1993","unstructured":"Dellagostin OA et al (1993) Construction and use of integrative vectors to express foreign genes in mycobacteria. Mol Microbiol 10(5):983\u2013993. https:\/\/doi.org\/10.1111\/j.1365-2958.1993.tb00970.x","journal-title":"Mol Microbiol"},{"issue":"6","key":"5093_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060831","volume":"10","author":"CC Dos Santos","year":"2022","unstructured":"Dos Santos CC et al (2022) Recombinant BCG-LTAK63 vaccine candidate for tuberculosis induces an inflammatory profile in human macrophages. Vaccines 10(6):831. https:\/\/doi.org\/10.3390\/vaccines10060831","journal-title":"Vaccines"},{"issue":"2","key":"5093_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.imbio.2009.04.002","volume":"215","author":"J Dou","year":"2010","unstructured":"Dou J et al (2010) Investigation of immunogenic effect of BCG priming and Ag85A\u2013GM-CSF boosting in BALB\/c mice model. Immunobiology 215(2):133\u2013142. https:\/\/doi.org\/10.1016\/j.imbio.2009.04.002","journal-title":"Immunobiology"},{"issue":"4","key":"5093_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.32074\/1591-951X-1006","volume":"116","author":"F Fortarezza","year":"2024","unstructured":"Fortarezza F et al (2024) The 2023 WHO updates on skin tumors: advances since the 2018 edition. Pathologica 116(4):193\u2013206. https:\/\/doi.org\/10.32074\/1591-951X-1006","journal-title":"Pathologica"},{"key":"5093_CR14","doi-asserted-by":"publisher","unstructured":"Gershenwald JE et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer 8th edition. CA Cancer J Clin 67(6):472\u2013492. https:\/\/doi.org\/10.3322\/caac.21409","DOI":"10.3322\/caac.21409"},{"key":"5093_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2024.1611586","volume":"30","author":"KA Grayson","year":"2024","unstructured":"Grayson KA, Greenlee JD, Himmel LE, Hapach LA, Reinhart-King CA, King MR (2024) Spatial distribution of tumor-associated macrophages in an orthotopic prostate cancer mouse model. Pathol Oncol Res 30:1611586. https:\/\/doi.org\/10.3389\/pore.2024.1611586","journal-title":"Pathol Oncol Res"},{"key":"5093_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01854-3","volume":"22","author":"N Hasan","year":"2023","unstructured":"Hasan N et al (2023) Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Mol Cancer 22:168. https:\/\/doi.org\/10.1186\/s12943-023-01854-3","journal-title":"Mol Cancer"},{"key":"5093_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2014.00321","volume":"5","author":"K Huygen","year":"2014","unstructured":"Huygen K (2014) The immunodominant T-cell epitopes of antigen 85 complex. Front Immunol 5:321. https:\/\/doi.org\/10.3389\/fimmu.2014.00321","journal-title":"Front Immunol"},{"key":"5093_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/joim.13037","volume":"288","author":"M Kremenovic","year":"2020","unstructured":"Kremenovic M, Schenk DJ (2020) Clinical and molecular insights into BCG immunotherapy for melanoma. J Intern Med 288:625\u2013640. https:\/\/doi.org\/10.1111\/joim.13037","journal-title":"J Intern Med"},{"key":"5093_CR19","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1074\/jbc.M111.298687","volume":"287","author":"CJ Kuo","year":"2012","unstructured":"Kuo CJ et al (2012) Novel mycobacterial antigen 85 complex binding motif on fibronectin. J Biol Chem 287:1892\u20131902","journal-title":"J Biol Chem"},{"issue":"4","key":"5093_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12026-024-09483-8","volume":"72","author":"W Liu","year":"2024","unstructured":"Liu W et al (2024) The immunosuppressive landscape in tumor microenvironment. Immunol Res 72(4):566\u2013582. https:\/\/doi.org\/10.1007\/s12026-024-09483-8","journal-title":"Immunol Res"},{"key":"5093_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"4","key":"5093_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","volume":"180","author":"DL Morton","year":"1974","unstructured":"Morton DL et al (1974) BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg 180(4):635\u2013643. https:\/\/doi.org\/10.1097\/00000658-197410000-00029","journal-title":"Ann Surg"},{"issue":"4","key":"5093_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/vaccines8040736","volume":"8","author":"AS Mustafa","year":"2020","unstructured":"Mustafa AS (2020) BCG as a vector for novel recombinant vaccines against infectious diseases and cancers. Vaccines (Basel) 8(4):736. https:\/\/doi.org\/10.3390\/vaccines8040736","journal-title":"Vaccines (Basel)"},{"key":"5093_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaad.2021.12.066","volume":"86","author":"M Perez","year":"2022","unstructured":"Perez M et al (2022) Skin cancer: primary, secondary, and tertiary prevention. Part I. J Am Acad Dermatol 86:255\u2013268. https:\/\/doi.org\/10.1016\/j.jaad.2021.12.066","journal-title":"J Am Acad Dermatol"},{"key":"5093_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00262-024-03693-7","volume":"73","author":"L Qin","year":"2024","unstructured":"Qin L et al (2024) Intratumor injection of BCG Ag85A high-affinity peptides enhances anti-tumor efficacy in PPD-positive melanoma. Cancer Immunol Immunother 73:103. https:\/\/doi.org\/10.1007\/s00262-024-03693-7","journal-title":"Cancer Immunol Immunother"},{"key":"5093_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"5093_CR27","doi-asserted-by":"publisher","first-page":"adv00136","DOI":"10.2340\/00015555-3491","volume":"100","author":"S Raimondi","year":"2020","unstructured":"Raimondi S et al (2020) Melanoma epidemiology and sun exposure. Acta Derm Venereol 100:adv00136. https:\/\/doi.org\/10.2340\/00015555-3491","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"5093_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/vaccines13040346","volume":"13","author":"A Seretis","year":"2025","unstructured":"Seretis A et al (2025) Multi-epitope DC vaccines with melanoma antigens for immunotherapy of melanoma. Vaccines (Basel) 13(4):346. https:\/\/doi.org\/10.3390\/vaccines13040346","journal-title":"Vaccines (Basel)"},{"key":"5093_CR29","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.3390\/jcm13185409","volume":"13","author":"A Shebrain","year":"2024","unstructured":"Shebrain A et al (2024) Advancements and challenges in personalized therapy for BRAF-mutant melanoma. J Clin Med 13:5409. https:\/\/doi.org\/10.3390\/jcm13185409","journal-title":"J Clin Med"},{"key":"5093_CR30","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1016\/j.vaccine.2021.09.040","volume":"39","author":"AK Singh","year":"2021","unstructured":"Singh AK et al (2021) Recombinant BCGs for tuberculosis and bladder cancer. Vaccine 39:7321\u20137331. https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.040","journal-title":"Vaccine"},{"key":"5093_CR31","first-page":"1693","volume":"25","author":"JP Tarrant","year":"2004","unstructured":"Tarrant JP et al (2004) Reduced tumorigenicity of B16\u2013F10 mouse melanoma cells transfected with mycobacterial antigen 85A. Int J Oncol 25:1693\u20131699","journal-title":"Int J Oncol"},{"key":"5093_CR32","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-20-3510","volume":"81","author":"S Tartey","year":"2021","unstructured":"Tartey S et al (2021) MyD88\/IL1R axis regulates PD-1 expression on tumor-associated macrophages. Cancer Res 81:2358\u20132372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3510","journal-title":"Cancer Res"},{"key":"5093_CR33","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.3390\/ijms23105384","volume":"23","author":"J T\u00edm\u00e1r","year":"2022","unstructured":"T\u00edm\u00e1r J, Lad\u00e1nyi A (2022) Molecular pathology of skin melanoma. Int J Mol Sci 23:5384. https:\/\/doi.org\/10.3390\/ijms23105384","journal-title":"Int J Mol Sci"},{"key":"5093_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M et al (2025) Immune evasion in cancer: mechanisms and therapeutic approaches. Signal Transduct Target Ther 10:227. https:\/\/doi.org\/10.1038\/s41392-025-02280-1","journal-title":"Signal Transduct Target Ther"},{"key":"5093_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","volume":"249","author":"AT Waickman","year":"2012","unstructured":"Waickman AT, Powell JD (2012) mTOR, metabolism, and T-cell differentiation. Immunol Rev 249:43\u201358. https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01152.x","journal-title":"Immunol Rev"},{"key":"5093_CR36","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2022.24888","volume":"329","author":"JY Wang","year":"2023","unstructured":"Wang JY et al (2023a) What is melanoma? JAMA 329:948. https:\/\/doi.org\/10.1001\/jama.2022.24888","journal-title":"JAMA"},{"key":"5093_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.854","volume":"11","author":"N Wang","year":"2023","unstructured":"Wang N et al (2023b) Mechanisms of Ag85A\/B DNA vaccine conferred immunotherapy. Immun Inflamm Dis 11:e854. https:\/\/doi.org\/10.1002\/iid3.854","journal-title":"Immun Inflamm Dis"},{"key":"5093_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","volume":"56","author":"HG Wiker","year":"1992","unstructured":"Wiker HG, Harboe M (1992) The antigen 85 complex. Microbiol Rev 56:648\u2013661","journal-title":"Microbiol Rev"},{"key":"5093_CR39","unstructured":"World Health Organization (2017) Radiation: ultraviolet (UV) radiation and skin cancer. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/radiation-ultraviolet-(uv)-radiation-and-skin-cancer (Accessed 21 June 2026)"},{"key":"5093_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.927031","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J et al (2022) Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens. Front Microbiol 13:927031. https:\/\/doi.org\/10.3389\/fmicb.2022.927031","journal-title":"Front Microbiol"},{"issue":"11","key":"5093_CR41","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/2326-6066.CIR-23-0627","volume":"12","author":"X Xiang","year":"2024","unstructured":"Xiang X, Wang K, Zhang H, Mou H, Shi Z, Tao Y, Song H, Lian Z, Wang S, Lu D, Wei X, Xie H, Zheng S, Wang J, Xu X (2024) Blocking CX3CR1+ tumor-associated macrophages enhances the efficacy of anti-PD1 therapy in hepatocellular carcinoma. Cancer Immunol Res 12(11):1603\u20131620. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-0627","journal-title":"Cancer Immunol Res"},{"key":"5093_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fonc.2017.00061","volume":"7","author":"J Yang","year":"2017","unstructured":"Yang J et al (2017) Insights into tumor microenvironment immune factors associated with melanoma regression by BCG. Front Oncol 7:61. https:\/\/doi.org\/10.3389\/fonc.2017.00061","journal-title":"Front Oncol"},{"key":"5093_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7774\/cevr.2014.3.2.155","volume":"3","author":"JM Yuk","year":"2014","unstructured":"Yuk JM, Jo EK (2014) Host immune responses to mycobacterial antigens. Clin Exp Vaccine Res 3:155\u2013167","journal-title":"Clin Exp Vaccine Res"},{"key":"5093_CR44","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.3892\/etm.2018.6851","volume":"16","author":"J Zhai","year":"2018","unstructured":"Zhai J et al (2018) Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity. Exp Ther Med 16:5123\u20135129. https:\/\/doi.org\/10.3892\/etm.2018.6851","journal-title":"Exp Ther Med"},{"key":"5093_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.intimp.2012.07.014","volume":"14","author":"P Zhang","year":"2012","unstructured":"Zhang P et al (2012) Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity. Int Immunopharmacol 14:252\u2013260. https:\/\/doi.org\/10.1016\/j.intimp.2012.07.014","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"5093_CR46","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/curroncol31020079","volume":"31","author":"S De Lidagoster","year":"2024","unstructured":"Lidagoster S, Ben-David R, De Leon B, Sfakianos JP (2024) BCG and alternative therapies to BCG therapy for non-muscle-invasive bladdercancer. Curr Oncol 31(2):1063\u20131078. https:\/\/doi.org\/10.3390\/curroncol31020079","journal-title":"Curr Oncol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05093-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:04:53Z","timestamp":1793030693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5093"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05093-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"534"}}